Modification of Enrofloxacin Treatment Regimens for Poultry Experimentally Infected with Salmonella enterica Serovar Typhimurium DT104 to Minimize Selection of Resistance

PMID: 170305642006

Key Findings

Mutations in gyrA were associated with reduced susceptibility to ciprofloxacin and resistance to nalidixic acid.

0gene entries

1mutation entry

AMR Mutations

Gene	Protein Change	Nucleotide Change	Mechanism	Organism	Resistance To	Database	Validation Status
gyrA	-	G260A	-	Salmonella enterica	Ciprofloxacin	Reslit	-